| 1058 |
Asundexian for Secondary Stroke Prevention (OCEANIC-STROKE trial)
|
2026-04-29 |
108 |
| 1057 |
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage (TRIDENT trial)
|
2026-04-29 |
114 |
| 1056 |
Rescue Versus First-Line Intracranial Stenting During Thrombectomy for Acute Ischemic Stroke: A Propensity-Weighted Analysis of the RESISTANT Registry
|
2026-04-29 |
128 |
| 1055 |
Vasospasm During Endovascular Treatment of Ischemic Stroke; Associated Factors, Impact on Outcomes, and the Effect of Intraarterial Nimodipine
|
2026-04-01 |
256 |
| 1054 |
Preceding Infections and Coagulation Biomarkers in Early-Onset Cryptogenic Ischemic Stroke
|
2026-04-01 |
207 |
| 1053 |
Time-Dependent Impact of Mismatch Profiles on Outcomes Following Endovascular Thrombectomy for Large Ischemic Stroke
|
2026-04-01 |
234 |
| 1052 |
Peri-Stenotic Stagnation Associates With Red Blood Cell-Rich Thrombi, Linked to Stroke Recurrence and Lesion Volume.
|
2026-02-27 |
358 |
| 1051 |
Microvascular and Macrovascular Cerebral Disease Profiles and Their Association With Cognitive Abilities: A Cross-Sectional Clinical Pathological Study.
|
2026-02-27 |
358 |
| 1050 |
Longitudinal Trajectories of Brain Health Risk Factors Measured by the Brain Care Score and Risk of Stroke, Dementia, and Depression.
|
2026-02-27 |
313 |
| 1049 |
Classification and Management of Ischemic Stroke in Patients With Active Cancer: A Scientific Statement From the American Heart Association.
|
2026-02-03 |
590 |
| 1048 |
Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial.
|
2026-02-03 |
475 |
| 1047 |
Switching From Aspirin Monotherapy After Noncardioembolic Stroke: A Systematic Review and Network Meta-Analysis.
|
2026-02-03 |
500 |
| 1046 |
Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
|
2026-01-02 |
563 |
| 1045 |
Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA)
|
2026-01-02 |
482 |
| 1044 |
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
|
2026-01-02 |
679 |